t:slim X2 Insulin Pump with Basal-IQ Technology

Automated Insulin Dosing , Threshold Suspend

FDA Premarket Approval P180008 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to update the occlusion detection software.

Devicet:slim X2 Insulin Pump with Basal-IQ Technology
Classification NameAutomated Insulin Dosing , Threshold Suspend
Generic NameAutomated Insulin Dosing , Threshold Suspend
ApplicantTandem Diabetes Care, Inc.
Date Received2018-08-31
Decision Date2018-11-29
PMAP180008
SupplementS001
Product CodeOZO
Advisory CommitteeClinical Chemistry
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address Tandem Diabetes Care, Inc. 11075 Roselle Street san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P180008Original Filing
S007 2019-11-20 30-day Notice
S006 2018-09-27 30-day Notice
S005 2018-09-12 30-day Notice
S004
S003 2018-08-31 Real-time Process
S002 2018-08-31 Real-time Process
S001 2018-08-31 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00853052007325 P180008 000
00853052007301 P180008 000
00853052007288 P180008 000
00853052007264 P180008 000
00850006613380 P180008 000
00850006613373 P180008 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.